Company intelligence / Profile preview

Wohlstand Pharmaceutical

Bangalore/Bengaluru, Karnataka, Indiawohlstand.cl ↗

Ownership: Private
Development stage: Phase 1

Overview

Wohlstand Pharma Private Limited focuses on research and development of pharmaceutical products, especially generics and complex generics, aiming at high safety and efficacy standards. The Chilean affiliate has advanced a proprietary antiviral candidate ("EMESY 3") into clinical studies targeting COVID‑19 and other viral infections. No published clinical results found as of now.

Therapeutic areas: Infectious Diseases
Modalities: Small molecules (generics and complex generics)
Industry: Biotech

Drug pipeline

1 asset

MC 3x3

Beyond the preview

Go deeper on Wohlstand Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wohlstand Pharmaceutical.

Explore the full profile